News & Views | Published:

ILC development: TCF-1 reporting in

Nature Immunology volume 16, pages 10111012 (2015) | Download Citation

The transcriptional regulator TCF-1 marks rare progenitor cells in adult bone marrow that have lost the potential to develop into the lymphocyte lineage but can give rise to all innate lymphoid cell lineages.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Immunol. 16, 1044–1050 (2015).

  2. 2.

    & Nature 517, 293–301 (2015).

  3. 3.

    et al. Immunity 40, 378–388 (2014).

  4. 4.

    et al. Cell 157, 340–356 (2014).

  5. 5.

    , , & Nature 508, 397–401 (2014).

  6. 6.

    , & Nat. Immunol. 11, 945–952 (2010).

  7. 7.

    et al. Nat. Immunol. 16, 599–608 (2015).

  8. 8.

    , et al. Elife 3, (2014).

  9. 9.

    et al. Nature 476, 63–68 (2011).

  10. 10.

    et al. Nat. Immunol. 13, 229–236 (2012).

  11. 11.

    , & J. Exp. Med. 209, 729–740 (2012).

  12. 12.

    et al. Cell Rep 10, 2043–2054 (2015).

Download references

Author information

Affiliations

  1. Jonathan Kaye is in the Research Division of Immunology, Departments of Biomedical Sciences and Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA, and the Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.

    • Jonathan Kaye

Authors

  1. Search for Jonathan Kaye in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Jonathan Kaye.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni.3276

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing